Thrombin receptor antagonists
View Patent ↗A series of compounds represented by the structural formulas and pharmaceutically acceptable isomers, salts, solvates and polymorphs thereof are disclosed. Also disclosed are pharmaceutical compositions containing said compounds and their use as thrombin receptor antagonists and binders to cannabinoid receptors.
1. A compound represented by any of the following structural formulas
or a pharmaceutically acceptable salt thereof.
2. A composition comprising at least one compound of claim 1 or a pharmaceutically acceptable salt thereof, and at least one pharmaceutically acceptable carrier.
3. A compound represented by the following structural formula:
or a pharmaceutically acceptable salt thereof.
4. A compound represented by the following structural formula
or a pharmaceutically acceptable salt thereof.
5. A compound represented by the following structural formula
or a pharmaceutically acceptable salt thereof.
6. A compound represented by the following structural formula
or a pharmaceutically acceptable salt thereof.
7. A compound represented by the following structural formula
or a pharmaceutically acceptable salt thereof.
8. A compound represented by the following structural formula
or a pharmaceutically acceptable salt thereof.
9. A compound represented by the following structural formula
or a pharmaceutically acceptable salt thereof.
10. A compound represented by the following structural formula
or a pharmaceutically acceptable salt thereof.
11. A compound represented by the following structural formula
or a pharmaceutically acceptable salt thereof.
12. A compound represented by the following structural formula
or a pharmaceutically acceptable salt thereof.
13. A composition comprising a compound represented by the following structural formula
or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier.
14. A composition comprising a compound represented by the following structural formula
or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier.
15. A composition comprising a compound represented by the following structural formula
or a pharmaceutically acceptable salt, and a pharmaceutically acceptable carrier.